William B.  Stilley, III net worth and biography
William B. Stilley, III Insider Alerts

Get notified the next time William B. Stilley, III buys or sells Adial Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

William Stilley, III Biography and Net Worth

William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business Development & Strategic Projects at Clinical Data, Inc. (NASDQ CLDA), where he worked on licensing and M&A transactions and was involved in management of Phase 3 clinical trials, production of Viibryd® for initial commercial launch of the product, and sourcing drug product and drug substance for the Phase 3 clinical trials of the Company’s vasodilator drug for myocardial stress imaging. He has advised both public and private companies on financing and M&A transactions, and has been the COO and CFO of a number of private companies. Before entering the business community, Mr. Stilley served as Captain in the U.S. Marine Corps.

 

Mr. Stilley has an MBA with honors from the Darden School of Business and a B.S. in Commerce/Marketing from the McIntire School of Commerce at the University of Virginia. He has guest lectured at the Darden School of Business in two courses on the management of life science companies, and serves on the Advisory Board of Virginia BIO, the statewide biotechnology organization, and previously served on Virginia BIO’s board of directors.

What is William B. Stilley, III's net worth?

The estimated net worth of William B. Stilley, III is at least $27,357.40 as of March 25th, 2020. Mr. Stilley, III owns 28,131 shares of Adial Pharmaceuticals stock worth more than $27,357 as of January 21st. This net worth evaluation does not reflect any other investments that Mr. Stilley, III may own. Learn More about William B. Stilley, III's net worth.

How do I contact William B. Stilley, III?

The corporate mailing address for Mr. Stilley, III and other Adial Pharmaceuticals executives is 1180 Seminole Trail Suite 495, Charlottesville VA, 22901. Adial Pharmaceuticals can also be reached via phone at (434) 422-9800 and via email at investor_relations@haynesintl.com. Learn More on William B. Stilley, III's contact information.

Has William B. Stilley, III been buying or selling shares of Adial Pharmaceuticals?

William B. Stilley, III has not been actively trading shares of Adial Pharmaceuticals during the last ninety days. Most recently, on Monday, November 29th, William B. Stilley III bought 400 shares of Adial Pharmaceuticals stock. The stock was acquired at an average cost of $64.75 per share, with a total value of $25,900.00. Learn More on William B. Stilley, III's trading history.

Who are Adial Pharmaceuticals' active insiders?

Adial Pharmaceuticals' insider roster includes Bankole Johnson (Insider), James Newman, Jr. (Director), and William Stilley, III (CEO). Learn More on Adial Pharmaceuticals' active insiders.

William B. Stilley, III Insider Trading History at Adial Pharmaceuticals

See Full Table

William B. Stilley, III Buying and Selling Activity at Adial Pharmaceuticals

This chart shows William B Stilley III's buying and selling at Adial Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

Adial Pharmaceuticals Company Overview

Adial Pharmaceuticals logo
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Read More

Today's Range

Now: $0.97
Low: $0.96
High: $1.02

50 Day Range

MA: $1.06
Low: $0.96
High: $1.23

2 Week Range

Now: $0.97
Low: $0.77
High: $4.17

Volume

96,664 shs

Average Volume

71,895 shs

Market Capitalization

$6.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21